Skip to main content

News

desc
29 October 2020

Doctor Anna Sandström Gerdtsson has received 2 million SEK from the Cancera foundation for Spatial analysis of immune infiltration for individualized treatment of ovarian cancer. The study, which will be one of the first projects of the recently established SpatialOmics@LU facility, will generate a multiplex depiction of the immune environment [...]

desc
23 October 2020

Doctor Magnus Jakobsson will present his work 28.10.2020 on the enzymology and clinical relevance of post‑translational modifications (PTM) of the universally conserved protein Hsp70. His work has uncovered the human enzyme METTL21A (Uniprotein ID: Q8WXB1) as a specific methyltransferase targeting Lys561 in Hsp70 and demonstrated the value of this [...]

desc
16 October 2020

Doctor Kathrin Zeller was 28.8.2020 appointed as Associate Professor in Immunotechnology by the Faculty of Engineering at Lund University. Her research focuses on in vitro models to investigate human cellular toxicity caused by various stresses, such as chemicals, chemical mixtures and nanoparticles. Currently, her team evaluates the capacity [...]

desc
23 September 2020

Aastha Sobti, one of the CanFaster Ph.D. students at the Department of Immunotechnology, represents cancer research at the EU online exhibition Science is Wonderful! Her work on tonsil cancer was selected as one of the forty best research projects with EU funding all around the world. The exhibition is part of the European Research and [...]

desc
8 September 2020

Professor Carl Borrebaeck of the Department of Immunotechnology and CREATE Health, a Strategic Center for Translational Cancer Research, has, as an expert scientist member of the EU Reference Laboratory for Alternatives to Animal Testing reviewed the scientific validity of non-animal-derived antibodies and non antibody affinity reagents used for [...]

desc
8 June 2020

Magnus Jakobsson has received a 400 k SEK research grant from the Crafoord Foundation to develop new mass spectrometry-based methods for the analysis of protein post-translational modifications.

desc
13 May 2020

A research team headed by Prof. Mats Ohlin of the Dept. of Immunotechnology has received funding for studies and development of human antibodies specific for the SARS-CoV-2 virus, the virus that cause COVID-19. The collaborative team includes researchers at Lund University, Skåne University Hospital, the Karolinska Institute, and the Royal [...]

desc
8 January 2020

Antibody technology and phenotypic discovery

desc
1 December 2019

Dr. Kristina Lundberg was today appointed as Associate Professor in Immunotechnology by the Faculty of Engineering at Lund University. Her research is focused on how to trigger the body’s own immune system to fight cancer. Currently, the team is performing studies on bladder cancer and acute myeloid leukemia. Based on analysis of immune cells [...]

desc
28 November 2019

Linnea Thörnqvist of the Department of Immunotechnology was recently awarded a prize for best poster in experimental immunology at the 3rd international meeting on Stochasticity and Control in Immune Repertoire, in Haifa, Israel. The poster covered a current study on so-called public antibodies associated with allergic response to the timothy grass [...]

Page Manager: jana.hagman@immun.lth.se | 2022-11-21